German high court rules against medicinal cannabis advertisements
March 30, 2026 by stratcann.com
German high court rules against medicinal cannabis advertisements
Germany’s Federal Court of Justice has ruled that advertising medical cannabis treatments violates national laws governing the promotion of medicinal products. The case focused on online platforms connecting patients with doctors, with the court determining that even general promotion of cannabis therapies can constitute prohibited advertising. The decision reinforces the classification of medical cannabis as a prescription-only medicine subject to strict pharmaceutical advertising rules. Industry representatives argue that the ruling may limit patients’ access to information about treatment options, particularly in a rapidly evolving digital healthcare environment. At the same time, the judgment highlights the tension between emerging cannabis business models and existing regulatory frameworks designed to protect consumers from misleading medical claims. The outcome could have broader implications for how medical cannabis services are marketed across Europe as regulators respond to the sector’s continued growth.
19.30% of the adult population are current smokers. There are approximately 13.9 million current smokers in Germany 22.10% of men are current smokers but only 16.50% of women.
SOURCE: GSTHR
